SCHEMBL16500897

SCHEMBL16500897

C=C/C=C(\C=C)c1ccc(Nc2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK13 O15264 1/20 0.40
▸ MAPK12 P53778 1/20 0.40
▸ MAPK11 Q15759 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ DEGS1 O15121 1/20 0.37
▸ PTPN1 P18031 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10110633 1.00 MAPK13 (0.40) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL18573463 0.85 MAPK13 (0.41) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL24680108 0.85 MAPK13 (0.36) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL20628349 0.85 MAPK13 (0.36) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL25821414 0.82 MAPK13 (0.39) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL23256716 0.81 MAPT (0.36) ALDH1A1ALOX12TDP1L3MBTL1PTPN1
SCHEMBL20628629 0.79 MAPK13 (0.34) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL27540011 0.78 AKT1 (0.48) MEN1KMT2AALDH1A1HSD17B10ALOX15
SCHEMBL18721564 0.78 AKT1 (0.48) MEN1KMT2AALDH1A1HSD17B10ALOX15
SCHEMBL24080769 0.78 RAB9A (0.41) MEN1KMT2AALDH1A1ALOX15ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024812-B2 Compound for organic-electric element, organic-electric element using same, and electronic device for same DUK SAN NEOLUX CO., LTD. (KR) 2021-06-01 — — US disclosed
EP-3390365-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-04-14 — — EP disclosed
EP-3419960-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-07-01 — — EP disclosed
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-03-02 — — US disclosed
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-03-02 — — US disclosed
US-20110297924-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-12-08 — — US disclosed
US-20110297924-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024812-B2 Compound for organic-electric element, organic-electric element using same, and electronic device for same PIEZO1, OR10J3, OR51E2 MAPK13 2177/4885MAPK12 2439/4885MAPK11 1695/4885
US-20170062728-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, OR51E2, PIEZO1 MAPK13 1853/4885MAPK12 1778/4885MAPK11 1284/4885
US-20110297924-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC18A2, SLC18A1, SLC7A5 MAPK13 2737/4885MAPK12 3017/4885MAPK11 2759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback